{
    "snomed_indications": [
        {
            "reasoning": "\"In the United States, gabapentin is officially indicated for the treatment of postherpetic neuralgia in adults...\"",
            "extracted_at": "2025-08-02T00:14:10.577",
            "confirmed": true,
            "evidence": true,
            "snomed_term": "Postherpetic neuralgia",
            "confidence": 0.9,
            "snomed_code": "12749009"
        }
    ],
    "drug_name": "Gabapentin",
    "metadata": {
        "total_indications_found": 1,
        "approach": "drugbank_snomed_extraction",
        "model_used": "llama3.2",
        "confirmation_rate_percent": 100,
        "processing_time_seconds": 19.135226011276245,
        "confidence_threshold": 0.6,
        "confirmed_indications": 1,
        "original_indication_text": "In the United States, gabapentin is officially indicated for the treatment of postherpetic neuralgia in adults and for the adjunctive treatment of partial-onset seizures, with or without secondary generalization, in patients 3 years of age and older.[L8717] In Europe, gabapentin is indicated for adjunctive therapy in the treatment of partial-onset seizures, with or without secondary generalization, in patients 6 years of age and older and as monotherapy in patients 12 years of age and older. It is also used in adults for the treatment of various types of peripheral neuropathic pain, such as painful diabetic neuropathy.[L8732]",
        "processing_timestamp": "2025-08-02T00:14:10.577"
    },
    "debug_info": {
        "processing_notes": "Successful SNOMED CT extraction from DrugBank text",
        "failure_reason": "",
        "indication_text_length": 633,
        "llm_failed": false,
        "raw_llm_response": "Research Finding N:\nSNOMED_CODE: 12749009\nSNOMED_TERM: Postherpetic neuralgia\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: \"In the United States, gabapentin is officially indicated for the treatment of postherpetic neuralgia in adults...\"\n\nResearch Finding N:\nSNOMED_CODE: 12749009\nSNOMED_TERM: Postherpetic neuralgia\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: \"In Europe, gabapentin is indicated for adjunctive therapy in the treatment of partial-onset seizures, with or without secondary generalization, in patients 6 years of age and older as monotherapy in patients 12 years of age and older.\"\n\nResearch Finding N:\nSNOMED_CODE: 12749009\nSNOMED_TERM: Postherpetic neuralgia\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: \"It is also used in adults for the treatment of various types of peripheral neuropathic pain, such as painful diabetic neuropathy.\"\n\nResearch Finding N:\nSNOMED_CODE: 12749009\nSNOMED_TERM: Postherpetic neuralgia\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: \"In the United States, gabapentin is officially indicated for the treatment of postherpetic neuralgia in adults and for the adjunctive treatment of partial-onset seizures...\"\n\nResearch Finding N:\nSNOMED_CODE: 12749009\nSNOMED_TERM: Postherpetic neuralgia\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: \"In Europe, gabapentin is indicated for adjunctive therapy in the treatment of partial-onset seizures, with or without secondary generalization, in patients 6 years of age and older as monotherapy...\"\n\nResearch Finding N:\nSNOMED_CODE: 12749009\nSNOMED_TERM: Postherpetic neuralgia\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: \"It is also used in adults for the treatment of various types of peripheral neuropathic pain, such as painful diabetic neuropathy.\"\n\nResearch Finding N:\nSNOMED_CODE: 12749009\nSNOMED_TERM: Postherpetic neuralgia\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: \"In the United States, gabapentin is officially indicated for the treatment of postherpetic neuralgia in adults and for the adjunctive treatment of partial-onset seizures...\"\n\nResearch Finding N:\nSNOMED_CODE: 12749009\nSNOMED_TERM: Postherpetic neuralgia\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: \"In Europe, gabapentin is indicated for adjunctive therapy in the treatment of partial-onset seizures, with or without secondary generalization, in patients 6 years of age and older as monotherapy...\"\n\nResearch Finding N:\nSNOMED_CODE: 12749009\nSNOMED.Term: Postherpetic neuralgia\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: \"It is also used in adults for the treatment of various types of peripheral neuropathic pain, such as painful diabetic neuropathy.\"\n\nResearch Finding N:\nSNOMED_CODE: 12749009\nSNOMED_TERM: Postherpetic neuralgia\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: \"In the United States, gabapentin is officially indicated for the treatment of postherpetic neuralgia in adults and for the adjunctive treatment of partial-onset seizures...\"\n\nResearch Finding N:\nSNOMED_CODE: 12749009\nSNOMED_TERM: Postherpetic neuralgia\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: \"In Europe, gabapentin is indicated for adjunctive therapy in the treatment of partial-onset seizures, with or without secondary generalization, in patients 6 years of age and older as monotherapy...\"\n\nResearch Finding N:\nSNOMED_CODE: 12749009\nSNOMED_TERM: Postherpetic neuralgia\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: \"It is also used in adults for the treatment of various types of peripheral neuropathic pain, such as painful diabetic neuropathy.\"\n\nResearch Finding N:\nSNOMED_CODE: 12749009\nSNOMED_TERM: Postherpetic neuralgia\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: \"In the United States, gabapentin is officially indicated for the treatment of postherpetic neuralgia in adults and for the adjunctive treatment of partial-onset seizures...\"\n\nResearch Finding N:\nSNOMED_CODE: 12749009\nSNOMED_TERM: Postherpetic neuralgia\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: \"In Europe, gabapentin is indicated for adjunctive therapy in the treatment of partial-onset seizures, with or without secondary generalization, in patients 6 years of age and older as monotherapy...\"\n\nResearch Finding N:\nSNOMED_CODE: 12749009\nSNOMED_TERM: Postherpetic neuralgia\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: \"It is also used in adults for the treatment of various types of peripheral neuropathic pain, such as painful diabetic neuropathy.\"\n\nResearch Finding N:\nSNOMED_CODE: 12749009\nSNOMED_TERM: Postherpetic neuralgia\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: \"In the United States, gabapentin is officially indicated for the treatment of postherpetic neuralgia in adults and for the adjunctive treatment of partial-onset seizures...\"\n\nResearch Finding N:\nSNOMED_CODE: 12749009\nSNOMED_TERM: Postherpetic neuralgia\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: \"In Europe, gabapentin is indicated for adjunctive therapy in the treatment of partial-onset seizures, with or without secondary generalization, in patients 6 years of age and older as monotherapy...\"\n\nResearch Finding N:\nSNOMED_CODE: 12749009\nSNOMED_TERM: Postherpetic neuralgia\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: \"It is also used in adults for the treatment of various types of peripheral neuropathic pain, such as painful diabetic neuropathy.\"\n\nResearch Finding N:\nSNOMED_CODE: 12749009\nSNOMED.Term: Postherpetic neuralgia\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: \"In the United States, gabapentin is officially indicated for the treatment of postherpetic neuralgia in adults and for the adjunctive treatment of partial-onset seizures...\"\n\nResearch Finding N:\nSNOMED_CODE: 12749009\nSNOMED_TERM: Postherpetic neuralgia\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: \"In Europe, gabapentin is indicated for adjunctive therapy in the treatment of partial-onset seizures, with or without secondary generalization, in patients 6 years of age and older as monotherapy...\"\n\nResearch Finding N:\nSNOMED_CODE: 12749009\nSNOMED.Term: Postherpetic neuralgia\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: \"It is also used in adults for the treatment of various types of peripheral neuropathic pain, such as painful diabetic neuropathy.\"\n\nResearch Finding N:\nSNOMED_CODE: 12749009\nSNOMED.Term: Postherpetic neuralgia\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: \"In the United States, gabapentin is officially indicated for the treatment of postherpetic neuralgia in adults and for the adjunctive treatment of partial-onset seizures...\"\n\nResearch Finding N:\nSNOMED_CODE: 12749009\nSNOMED.Term: Postherpetic neuralgia\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: \"In Europe, gabapentin is indicated for adjunctive therapy in the treatment of partial-onset seizures, with or without secondary generalization, in patients 6 years of age and older as monotherapy...\"\n\nResearch Finding N:\nSNOMED_CODE: 12749009\nSNOMED.Term: Postherpetic neuralgia\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: \"It is also used in adults for the treatment of various types of peripheral neuropathic pain, such as painful diabetic neuropathy.\"\n\nResearch Finding N:\nSNOMED_CODE: 12749009\nSNOMED_TERM: Postherpetic neuralgia\nCONFIDENCE: 0.9\nEVIDENCE: YES\nREASONING: \"In the United States, gabapentin is officially indicated for the treatment of postherpetic neuralgia in adults and for the adjunctive treatment of partial-onset seizures...\"\n\nResearch"
    }
}